Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs
Dados Bibliográficos
Environmental health · Family medicine · Harm · Harm reduction · Health care · Hepatitis C · Political science · Public health · Public relations · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Nursing · Virology
Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City
Accessibility of Needle and Syringe Programs and Injecting and Sharing Risk Behaviors in High Hepatitis C Virus Prevalence Settings
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs
An Investigation of the Side Effects, Patient Feedback, and Physiological Changes Associated with Direct-Acting Antiviral Therapy for Hepatitis C
Epidemiology of hepatitis B and C among risk groups in Czechia
Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
It’s Your Right – implementation and outcomes of a co-designed national Australian hepatitis C health promotion campaign
A gender lens is needed in hepatitis C elimination research
Stigma is where the harm comes from”
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Hepatitis C treatment access and uptake for people who inject drugs
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Public health and international drug policy
Prevention of HIV infection for people who inject drugs
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
The Moral Economies of Homeless Heroin Addicts
Policing Drug Users in Russia
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
Republished research: Implementation research: what it is and how to do it
Epidemiology and natural history of HCV infection
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs
Treatment and care for injecting drug users with HIV infection
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
Developing and evaluating complex interventions
Patient and service user engagement in research
Access to HIV treatment and care for people who inject drugs in Kenya
Internalized HIV and Drug Stigmas
Tensions in relation
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics
Examining structural violence in opioid pharmacotherapy treatment in Australia
Beyond the willing & the waiting’ — The role of peer-based approaches in hepatitis C diagnosis & treatment
Interventions to prevent HIV and Hepatitis C in people who inject drugs
Human rights and access to hepatitis C treatment for people who inject drugs
Integrating HCV services for drug users
Shouting through bullet-proof glass
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010
Understanding real-world adherence in the directly acting antiviral era
Drug policy constellations
Comparative policy analysis for alcohol and drugs
How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
Taming systems to create enabling environments for HCV treatment
| Obras citantes distintas | 9 |
|---|---|
| Citações por ano | 1,29 |
| Intervalo de citações | 2019 - 2026 (8) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 9 |